SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001140361-22-046379
Filing Date
2022-12-20
Accepted
2022-12-20 16:30:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D brhc10045710_sc13d.htm SC 13D 48148
  Complete submission text file 0001140361-22-046379.txt   49737
Mailing Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121
Business Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-42217 | Film No.: 221475196
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1395 BRICKELL AVENUE SUITE 800 MIAMI FL 33131
Business Address
Singer Nicholas Jason (Filed by) CIK: 0001828224 (see all company filings)

Type: SC 13D